⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7235464 | 1.00 | — | — | |
| SCHEMBL7235467 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL31105856 | 0.98 | CYP1A2 (0.37) | — | |
| SCHEMBL30114924 | 0.85 | — | — | |
| Palmitic Acid SCHEMBL23162434 | 0.81 | GPR84 (0.53) | — | |
| SCHEMBL29955590 | 0.80 | HSD17B10 (0.34) | — | |
| SCHEMBL20337248 | 0.79 | — | — | |
| SCHEMBL20337207 | 0.79 | — | — | |
| SCHEMBL8997575 | 0.77 | CA14 (0.43) | — | |
| SCHEMBL6285291 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126052-B1 | USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING IMMUNOMODULATORY EFFECTS IN CANCER TREATMENT | FUNDACAO GIMM GULBENKIAN INST FOR MOLECULAR MEDICINE (PT) | 2025-12-24 | — | — | EP | disclosed |
| US-12459921-B2 | Isoindoline compound, preparation method, pharmaceutical composition and use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2025-11-04 | — | — | US | disclosed |
| EP-4639171-A2 | (POLY)LABEL SIGNAL ENHANCER | Roche Diagnostics GmbH (DE) | 2025-10-29 | — | — | EP | disclosed |
| EP-4543907-A1 | GQ/11 PROTEIN PEPTIDOMIMETICS | Vrije Universiteit Brussel (BE) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025049691-A1 | PEPTIDE-BASED COATING MOLECULES FOR STABILIZING DNA NANOSTRUCTURES AND IMPARTING BIOLOGICAL ACTIVITY | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-119192401-A | Iso-tandem bicyclic peptide complexes | 拜斯科技术开发有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024133457-A2 | (POLY)LABEL SIGNAL ENHANCER | ROCHE DIAGNOSTICS GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| US-20240083958-A1 | G PROTEIN PEPTIDOMIMETICS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2024-03-14 | — | — | US | disclosed |
| WO-2023247717-A1 | GQ/11 PROTEIN PEPTIDOMIMETICS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2023-12-28 | — | — | WO | disclosed |
| EP-4263592-A1 | G PROTEIN PEPTIDOMIMETICS | Vrije Universiteit Brussel (BE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2010034029-A1 | PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010034034-A1 | PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| US-20090326192-A1 | BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2009-12-31 | — | — | US | disclosed |
| EP-2114428-A2 | TRIAZOLE MACROCYCLE SYSTEMS | Aileron Therapeutics, Inc. (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20090275519-A1 | Therapeutic peptidomimetic macrocycles | AILERON THERAPEUTICS, INC. (US) | 2009-11-05 | — | — | US | disclosed |
| WO-2009126292-A2 | BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2009-10-15 | — | — | WO | disclosed |
| WO-2009099677-A2 | THERAPEUTIC PEPTIDOMIMETIC MACROCYCLES | AILERON THERAPEUTICS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20080262200-A1 | Triazole Macrocycle Systems | AILERON THERAPEUTICS, INC., A DELAWARE CORPORATION (US) | 2008-10-23 | — | — | US | disclosed |
| WO-2008104000-A2 | TRIAZOLE MACROCYCLE SYSTEMS | AILERON THERAPEUTICS, INC. (US) | 2008-08-28 | — | — | WO | disclosed |
| CN-1525978-A | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | 伊邓药品公司 | 2004-09-01 | — | — | CN | disclosed |